Weaver Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.64M Sell
18,974
-425
-2% -$99K 1.01% 29
2025
Q4
$4.01M Buy
19,399
+1,315
+7% +$260K 0.85% 32
2025
Q3
$3.35M Buy
18,084
+6,535
+57% +$1.12M 0.73% 38
2025
Q2
$1.76M Sell
11,549
-712
-6% -$109K 0.43% 58
2025
Q1
$2.03M Buy
12,261
+2,891
+31% +$452K 0.54% 47
2024
Q4
$1.36M Sell
9,370
-3,393
-27% -$526K 0.38% 72
2024
Q3
$2.07M Buy
12,763
+3,526
+38% +$562K 0.62% 48
2024
Q2
$1.35M Sell
9,237
-5,425
-37% -$807K 0.43% 68
2024
Q1
$2.32M Buy
14,662
+3,757
+34% +$598K 0.79% 40
2023
Q4
$1.71M Buy
+10,905
New +$1.67M 0.68% 47

Other funds holding JNJ

Weaver Capital Management's JNJ Position: Q1 2026 in Review

Weaver Capital Management reduced its Johnson & Johnson (JNJ) stake by 2.2% in Q1 2026, selling an estimated $99K and leaving 18,974 shares worth $4.64M. The position accounts for 1.01% of the portfolio, ranked #29.

Weaver Capital Management first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Weaver Capital Management held 18,974 shares of Johnson & Johnson worth $4.64M as of Q1 2026.
  • Weaver Capital Management sold 425 Johnson & Johnson shares in Q1 2026, an estimated $99K.
  • Johnson & Johnson made up 1.01% of Weaver Capital Management's portfolio in Q1 2026, its #29 holding.
  • Weaver Capital Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Weaver Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.